Core Competencies in Health-System Pharmacy: Oncology Pharmacy Practice
Core Competencies in Health-System Pharmacy: Oncology Pharmacy Practice is organized by Power-Pak C.E. - Continuing Education for Pharmacists & Pharmacy Technicians.
Published: July 24, 2021
Expires: July 24, 2024
Goal:
To provide fundamental information to pharmacists on oncology pharmacy practice in the health-system setting.
Educational Objectives:
Upon completion of this program, participants should be better able to:
• DESCRIBE the efficacy, key toxicities, and management of FGFR inhibitors in metastatic cholangiocarcinoma and metastatic urothelial carcinoma
• DESCRIBE the efficacy, key toxicities, and management of RET inhibitors in medullary thyroid cancer and non-small cell lung cancer
• DESCRIBE the incidence of NTRK gene fusions and the efficacy and key toxicities of entrectinib and larotrectinib
• DEFINE the role of CAR T-cell therapy in acute lymphoblastic leukemia, non-Hodgkin lymphoma, and multiple myeloma
• IDENTIFY key toxicities of CAR T-cell therapy and how to manage these side effects
Additional details will be posted as soon as information is available.